Editor’s Note
**Editor’s Note:** Rohto Pharmaceutical has launched the DRX AZA Clear Serum, a new azelaic acid-based product for medical institutions, targeting the growing demand for dermatological skincare.
As more people visit aesthetic dermatology clinics for skin issue treatment and maintaining healthy skin, a new product featuring the popular skin-conditioning ingredient “azelaic acid” has been introduced. On July 21, Rohto Pharmaceutical launched the ‘DRX AZA Clear Serum’, a serum designed to be easily applied to the entire face, under its medical-exclusive skincare brand ‘DRX (R)’, at authorized medical institutions nationwide.
[Image: Details of ‘DRX AZA Clear Serum’]
‘DRX’ is a medical-exclusive brand that has pursued quality, usability, and ease of continuous use based on feedback from doctors and healthcare professionals who work directly with patients’ skin in clinical settings. Since launching the azelaic acid cream ‘AZA Clear (R)’ in 2011, the company has accumulated over 15 years of expertise and formulation technology related to azelaic acid.
Azelaic acid is a poorly soluble ingredient that is difficult to dissolve in both water and oil, requiring extremely high formulation technology, while its unique texture has also been a major challenge. The newly launched ‘DRX AZA Clear Serum’ is a notable product developed to address these issues by focusing on the texture of azelaic acid and utilizing proprietary technology.
Its biggest feature is that it incorporates “azelaic acid” itself—not a derivative—as a skin-conditioning ingredient while achieving a serum dosage form that is easy to blend into the entire face. With a smooth, spreadable texture, it is designed to be seamlessly integrated into daily skincare routines. This product is expected to be a reliable ally for those undergoing aesthetic medical treatments, as well as for individuals seeking to balance clinical treatment with home care, helping to maintain healthy skin every day.
The ‘DRX AZA Clear Serum’, combining expertise from specialized institutions and pharmaceutical technology, is available at open price starting July 21 at authorized hospitals and clinics nationwide. Purchase requires a medical consultation or counseling at a medical institution, so interested individuals should check the official website for authorized locations.
[Related Articles]
– It’s Not Too Late for Spot Care! Adult ‘Hidden Spots,’ Pores, and Past Sun Damage… Rohto Pharmaceutical Discusses Autumn/Winter Care and Melano CC Usage
– ‘Deoco Uncle’ Goes Viral: What Was Rohto Pharmaceutical’s Mindset? Cleanliness and Consideration Required in Odor-Conscious Japan
– Rainy Season ‘Hair Frizz’ Troubles… Could Social Media ‘Hacks’ Be the Key? ‘Deoco’ Developer Challenges Industry Norms for Hair
– ‘Tone-Up UV’: Dramatic Changes in Sunscreen Over 10 Years—From ‘No Tanning’ to Tone-Up? Entering the Era of ‘Added Value’ [Rohto Pharmaceutical]
– New Series from ‘Melano CC’ Launches: First Product is a Face Mask Targeting Pore Concerns
Last Updated: 7/22 (Wed) 12:35
ELSA
Search Keywords: Medical Aesthetics